Figure 1 | Scientific Reports

Figure 1

From: BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients

Figure 1

(A) qRT-PCR analysis revealed that the BCAT1 messenger RNA level is significantly increased in IDH1-wildtype patients compared with IDH1-mutant patients (P = 0.0021). (B,C) Immunohistochemistry and western blotting show that the BCAT1 protein expression level is higher in IDH1-wildtype patients compared with IDH1-mutants. NBr = Normal Brain, WT = wildtype, MT = mutant. We didn’t use cropping for western blot. (See Supplementary Fig. S1 for full-length blots).

Back to article page